Coronary Stents BioMatrixand BioMatrix Flex drug-eluting represents a combination product consisting of two key components:
Of a stent containing the active drug Biolimus A9™ incorporated in a biodegradable polymer coating
Delivery Systems
Composition: 316L medical-grade stainless steel. Long-term outcomes: Two of the largest studies (LEADERS and the e-Biomatrix registry) with more than 2,000 patients demonstrated good 5-year outcomes with low rates of cardiovascular events and in-stent restenosis below 7%
